Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500517 | SCV000594709 | uncertain significance | not specified | 2015-09-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001865605 | SCV002295879 | uncertain significance | Fanconi anemia | 2022-04-01 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 302 of the FANCG protein (p.Ser302Ile). This variant is present in population databases (rs61757386, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 435154). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002481613 | SCV002791531 | uncertain significance | Fanconi anemia complementation group G | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002481613 | SCV004199149 | uncertain significance | Fanconi anemia complementation group G | 2023-06-07 | criteria provided, single submitter | clinical testing |